Wealthspire Advisors (Maryland)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,068
Closed -$366K 480
2020
Q1
$366K Buy
2,068
+108
+6% +$20.3K 0.03% 275
2019
Q4
$375K Buy
1,960
+73
+4% +$13.2K 0.03% 324
2019
Q3
$318K Sell
1,887
-29
-2% -$4.72K 0.02% 336
2019
Q2
$321K Sell
1,916
-289
-13% -$40K 0.02% 336
2019
Q1
$323K Buy
2,205
+108
+5% +$15.7K 0.02% 335
2018
Q4
$280K Sell
2,097
-12
-0.6% -$1.97K 0.02% 338
2018
Q3
$402K Sell
2,109
-99
-4% -$18.2K 0.03% 286
2018
Q2
$368K Sell
2,208
-585
-21% -$93.9K 0.03% 308
2018
Q1
$470K Sell
2,793
-106
-4% -$17.8K 0.04% 254
2017
Q4
$474K Sell
2,899
-2,278
-44% -$409K 0.05% 260
2017
Q3
$1.06M Buy
5,177
+718
+16% +$167K 0.12% 124
2017
Q2
$1.08M Buy
4,459
+682
+18% +$160K 0.13% 115
2017
Q1
$902K Sell
3,777
-906
-19% -$211K 0.13% 106
2016
Q4
$983K Buy
4,683
+396
+9% +$82K 0.15% 103
2016
Q3
$987K Buy
4,287
+177
+4% +$43.3K 0.15% 100
2016
Q2
$950K Buy
4,110
+1,249
+44% +$288K 0.16% 97
2016
Q1
$767K Buy
2,861
+71
+3% +$20.3K 0.14% 110
2015
Q4
$872K Buy
+2,790
New +$831K 0.16% 98

Other funds holding AGN

Wealthspire Advisors (Maryland)'s AGN Position: Q2 2020 in Review

Wealthspire Advisors (Maryland) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,068 shares — an estimated $366K sold.

Wealthspire Advisors (Maryland) first reported a position in AGN in Q4 2015 and held it in 18 quarters. The position peaked at $1.08M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wealthspire Advisors (Maryland) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 2,068 Allergan plc shares in Q2 2020, an estimated $366K.
  • Wealthspire Advisors (Maryland) first reported a position in Allergan plc in Q4 2015 and held it in 18 quarters.
  • Wealthspire Advisors (Maryland)'s Allergan plc position peaked at $1.08M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2020, filed 14 Aug 2020.